Diabetes Care, Vol 18, Issue 4 517-522, Copyright © 1995 by American Diabetes Association

ARTICLES

Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms

WL Clarke, DJ Cox, LA Gonder-Frederick, D Julian, D Schlundt and W Polonsky
Department of Pediatrics, University of Virginia Health Sciences Center, Charlottesville 22908, USA.

OBJECTIVE--To prospectively evaluate the frequency and severity of hypoglycemic episodes in IDDM subjects who declare themselves to have reduced awareness of hypoglycemia, to validate their self-designations in their natural environment, and to determine objectively the presence or absence of autonomic and neuroglycopenic symptoms associated with their low blood glucose (BG) levels. RESEARCH DESIGN AND METHODS--A total of 78 insulin-dependent diabetes mellitus (IDDM) subjects (mean age 38.3 +/- 9.2 years; duration of diabetes 19.3 +/- 10.4 years) completed two sets of assessments separated by 6 months. The assessments included reports of frequency and severity of low BG, symptoms associated with low BG, and a BG symptom/estimation trial using a hand-held computer (HHC). Diaries of hypoglycemic episodes were kept for the intervening 6 months. HbA1 levels were determined at each assessment. RESULTS--Of the subjects, 39 declared themselves as having reduced awareness of hypoglycemia (reduced-awareness subjects). There were no differences between these reduced-awareness subjects and aware subjects with regard to age, sex, disease duration, insulin dose, or HbA1. During the HHC trials, reduced-awareness subjects were significantly less accurate in detecting BG < 3.9 mmol/l (33.2 +/- 47 vs. 47.6 +/- 50% detection, P = 0.001) and had significantly fewer autonomic (0.41 +/- 0.82 vs. 1.08 +/- 1.22, P = 0.006, reduced-awareness vs. aware) and neuroglycopenic (0.44 +/- 0.85 vs. 1.18 +/- 1.32, P = 0.004, reduced-awareness vs. aware) symptoms per subject. Prospective diary records revealed that reduced-awareness subjects experienced more moderate (351 vs. 238, P = 0.026) and severe (50 vs. 17, P = 0.0062) hypoglycemic events. The second assessment results were similar to the first and verified the reliability of the data. CONCLUSIONS--IDDM subjects who believe they have reduced awareness of hypoglycemia are generally correct. They have a history of more moderate and severe hypoglycemia, are less accurate at detecting BG < 3.9 mmol/l, and prospectively experience more moderate and severe hypoglycemia than do aware subjects. Neither disease duration nor level of glucose control explains their reduced awareness of hypoglycemia. Reduced-awareness individuals may benefit from interventions designed to teach them to recognize all of their potential early warning symptoms.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. B. Leitao, T. Tharavanij, P. Cure, A. Pileggi, D. A. Baidal, C. Ricordi, and R. Alejandro Restoration of Hypoglycemia Awareness After Islet Transplantation Diabetes Care, November 1, 2008; 31(11): 2113 - 2115. [Abstract] [Full Text] [PDF]

				N. N. Zammitt, R. E. Warren, I. J. Deary, and B. M. Frier Delayed Recovery of Cognitive Function Following Hypoglycemia in Adults With Type 1 Diabetes: Effect of Impaired Awareness of Hypoglycemia Diabetes, March 1, 2008; 57(3): 732 - 736. [Abstract] [Full Text] [PDF]

				U. Pedersen-Bjergaard, T. Hoi-Hansen, and B. Thorsteinsson An Evaluation of Methods of Assessing Impaired Awareness of Hypoglycemia in Type 1 Diabetes: Response to Geddes et al. Diabetes Care, November 1, 2007; 30(11): e112 - e112. [Full Text] [PDF]

				J. Geddes and B. M. Frier An Evaluation of Methods of Assessing Impaired Awareness of Hypoglycemia in Type 1 Diabetes: Response to Pedersen-Bjergaard et al. Diabetes Care, November 1, 2007; 30(11): e113 - e113. [Full Text] [PDF]

				A. D.M. Stork, T. W. van Haeften, and T. F. Veneman The Decision Not to Drive During Hypoglycemia in Patients With Type 1 and Type 2 Diabetes According to Hypoglycemia Awareness Diabetes Care, November 1, 2007; 30(11): 2822 - 2826. [Abstract] [Full Text] [PDF]

				J. T. Dunn, I. Cranston, P. K. Marsden, S. A. Amiel, and L. J. Reed Attenuation of Amydgala and Frontal Cortical Responses to Low Blood Glucose Concentration in Asymptomatic Hypoglycemia in Type 1 Diabetes: A New Player in Hypoglycemia Unawareness? Diabetes, November 1, 2007; 56(11): 2766 - 2773. [Abstract] [Full Text] [PDF]

				J. Geddes, R. J. Wright, N. N. Zammitt, I. J. Deary, and B. M. Frier An Evaluation of Methods of Assessing Impaired Awareness of Hypoglycemia in Type 1 Diabetes Diabetes Care, July 1, 2007; 30(7): 1868 - 1870. [Full Text] [PDF]

				C. Meyer, A. Vaksman, D. M. Thompson, M. A. Fung, G. L. Warnock, A.M. J. Shapiro, C. Ricordi, and B. J. Hering Islet transplantation. N. Engl. J. Med., March 1, 2007; 356(9): 963 - 964. [Full Text] [PDF]

				M. R. Rickels, M. H. Schutta, R. Mueller, S. Kapoor, J. F. Markmann, A. Naji, and K. L. Teff Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 873 - 879. [Abstract] [Full Text] [PDF]

				A. M. Maguire, M. E. Craig, A. Craighead, A. K.F. Chan, J. M. Cusumano, S. J. Hing, M. Silink, N. J. Howard, and K. C. Donaghue Autonomic Nerve Testing Predicts the Development of Complications: A 12-year follow-up study Diabetes Care, January 1, 2007; 30(1): 77 - 82. [Abstract] [Full Text] [PDF]

				B. E. De Galan, P. De Mol, L. Wennekes, B. J. J. Schouwenberg, and P. Smits Preserved Sensitivity to {beta}2-Adrenergic Receptor Agonists in Patients with Type 1 Diabetes Mellitus and Hypoglycemia Unawareness J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2878 - 2881. [Abstract] [Full Text] [PDF]

				M. M. Lane Advancing the Science of Perceptual Accuracy in Pediatric Asthma and Diabetes J. Pediatr. Psychol., April 1, 2006; 31(3): 233 - 245. [Abstract] [Full Text] [PDF]

				M. R. Rickels, M. H. Schutta, R. Mueller, J. F. Markmann, C. F. Barker, A. Naji, and K. L. Teff Islet Cell Hormonal Responses to Hypoglycemia After Human Islet Transplantation for Type 1 Diabetes Diabetes, November 1, 2005; 54(11): 3205 - 3211. [Abstract] [Full Text] [PDF]

				B. J. Hering, R. Kandaswamy, J. D. Ansite, P. M. Eckman, M. Nakano, T. Sawada, I. Matsumoto, S.-H. Ihm, H.-J. Zhang, J. Parkey, et al. Single-Donor, Marginal-Dose Islet Transplantation in Patients With Type 1 Diabetes JAMA, February 16, 2005; 293(7): 830 - 835. [Abstract] [Full Text] [PDF]

				M. L. Evans, R. J. McCrimmon, D. E. Flanagan, T. Keshavarz, X. Fan, E. C. McNay, R. J. Jacob, and R. S. Sherwin Hypothalamic ATP-sensitive K + Channels Play a Key Role in Sensing Hypoglycemia and Triggering Counterregulatory Epinephrine and Glucagon Responses Diabetes, October 1, 2004; 53(10): 2542 - 2551. [Abstract] [Full Text] [PDF]

				E. A. Ryan, T. Shandro, K. Green, B. W. Paty, P. A. Senior, D. Bigam, A.M. J. Shapiro, and M.-C. Vantyghem Assessment of the Severity of Hypoglycemia and Glycemic Lability in Type 1 Diabetic Subjects Undergoing Islet Transplantation Diabetes, April 1, 2004; 53(4): 955 - 962. [Abstract] [Full Text] [PDF]

				R. J. McCrimmon, M. L. Evans, R. J. Jacob, X. Fan, Y. Zhu, G. I. Shulman, and R. S. Sherwin AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1076 - E1083. [Abstract] [Full Text] [PDF]

				I. M. Evers, E. W.M.T. ter Braak, H. W. de Valk, B. van der Schoot, N. Janssen, and G. H.A. Visser Risk Indicators Predictive for Severe Hypoglycemia During the First Trimester of Type 1 Diabetic Pregnancy Diabetes Care, March 1, 2002; 25(3): 554 - 559. [Abstract] [Full Text] [PDF]

				B. P. Kovatchev, D. J. Cox, L. S. Farhy, M. Straume, L. Gonder-Frederick, and W. L. Clarke Episodes of Severe Hypoglycemia in Type 1 Diabetes Are Preceded and Followed within 48 Hours by Measurable Disturbances in Blood Glucose J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4287 - 4292. [Abstract] [Full Text]

				J. Weiss and S. A. Hutchinson Warnings about Vulnerability in Clients with Diabetes and Hypertension Qual Health Res, July 1, 2000; 10(4): 521 - 537. [Abstract] [PDF]

				M. L. Evans, K. Matyka, J. Lomas, A. Pernet, I. C. P. Cranston, I. Macdonald, and S. A. Amiel Reduced Counterregulation during Hypoglycemia with Raised Circulating Nonglucose Lipid Substrates: Evidence for Regional Differences in Metabolic Capacity in the Human Brain? J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2952 - 2959. [Abstract] [Full Text]

				W. L. Clarke, D. J. Cox, L. A. Gonder-Frederick, D. Julian, D. Schlundt, and W. Polonsky The Relationship Between Nonroutine Use of Insulin, Food, and Exercise and the Occurrence of Hypoglycemia in Adults With IDDM and Varying Degrees of Hypoglycemic Awareness and Metabolic Control The Diabetes Educator, January 1, 1997; 23(1): 55 - 58. [PDF]